BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ARMI - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.armiusa.org
X-WR-CALDESC:Events for ARMI
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260706
DTEND;VALUE=DATE:20260709
DTSTAMP:20260615T101508
CREATED:20260529T013621Z
LAST-MODIFIED:20260529T013738Z
UID:10001802-1783296000-1783555199@www.armiusa.org
SUMMARY:Cell & Gene Therapy Summit 2026
DESCRIPTION:Advancing the Path from Innovation to Commercially Viable Therapies\nThe Cell & Gene Therapy Summit 2026 brings together leaders from industry\, academia\, healthcare\, and government to discuss the latest advancements in cell and gene therapy development\, manufacturing\, commercialization\, and patient access. \nThis year’s summit focuses on advancing cell and gene therapies through innovation\, technology\, and collaboration\, covering topics ranging from manufacturing and process development to regulatory strategy\, commercialization\, and market adoption. The event convenes experts across the therapeutic development lifecycle to address the challenges and opportunities shaping the future of advanced therapies. \nJennifer MacDonald\, Chief Operating Officer of ARMI\, will serve as a panelist during the session\, “Creating a Commercially Viable Therapy.” The discussion will examine the critical factors required to successfully translate promising therapies from research and clinical development into scalable\, commercially sustainable products capable of reaching patients. \nARMI’s participation reflects its commitment to advancing manufacturing innovation\, strengthening supply chains\, and addressing the practical challenges associated with scaling regenerative medicine and advanced therapy products. \nJoin leaders from across the cell and gene therapy community in Boston for three days of technical presentations\, industry insights\, networking\, and collaboration. \n 
URL:https://www.armiusa.org/event/cell-gene-therapy-summit-2026/
LOCATION:Four Points by Sheraton Wakefield Boston Hotel & Conference Center\, One Audubon Rd\, Wakefield\, MA\, 01880\, United States
CATEGORIES:ARMI,BioFabUSA
ATTACH;FMTTYPE=image/png:https://www.armiusa.org/wp-content/uploads/2022/05/PartnerLive-e1653358779467.png
END:VEVENT
END:VCALENDAR